Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/20/25 16:36 | 3/18/25 | CADL | Health | BioPrd | Biological Products, (No Diag | Nichols William Garrett | MA | O | Chief Me | 1 | S.d | -397 | 8.76 | 0 | -45 | 52 | D | |||||||||||||||
3/20/25 16:36 | 3/18/25 | CADL | Health | BioPrd | Biological Products, (No Diag | Barone Francesca | MA | O | Chief Sc | 1 | S.d | -282 | 8.76 | 0 | -32 | 97 | D | |||||||||||||||
3/20/25 16:35 | 3/18/25 | CADL | Health | BioPrd | Biological Products, (No Diag | Tak Paul Peter | MA | DO | CEO | 1 | S.m | -230 | 8.77 | 0 | -26 | 226 | D | |||||||||||||||
3/20/25 16:35 | 3/17/25 | CADL | Health | BioPrd | Biological Products, (No Diag | Tyagarajan Seshu | MA | O | CTO | 2 | S.d | -552 | 8.82 | 0 | -63 | 86 | D | |||||||||||||||
3/19/25 16:06 | 3/17/25 | CADL | Health | BioPrd | Biological Products, (No Diag | Schoch Charles | MA | O | See Rema | 1 | S | -44 | 8.83 | 0 | -5 | 38 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |